Fortress Biotech, Inc. (FBIO)
↓ Download CSV- Sector Manufacturing
- Incorporated DE
- Fiscal year ends Dec 31
In fiscal 2025, Fortress Biotech, Inc. reported revenue of $63.26M, up 9.7% from the prior year. The company was profitable, with a net margin of 10.8%. It held $185.55M in total assets against $123.36M in total liabilities.
Key ratios (FY2025)
-111.0%
Operating margin
10.8%
Net margin
13.7%
Return on equity
+9.7%
Revenue growth (YoY)
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $63.26M | $57.67M | $84.51M | $75.74M | $68.79M | $45.60M | $36.63M | $26.88M | $17.25M | $16.48M |
| Cost of Revenue | $20.92M | $20.88M | $22.89M | $30.77M | $32.08M | $14.59M | $10.53M | $6.12M | $3.66M | — |
| Operating Income | -$70.22M | -$110.38M | -$142.34M | -$203.56M | -$188.54M | -$94.27M | -$110.82M | -$120.00M | -$89.80M | -$65.71M |
| Net Income | $6.82M | -$46.00M | -$60.64M | -$86.58M | -$64.70M | -$46.53M | -$39.96M | -$84.15M | -$66.88M | -$55.09M |
| EPS (Diluted) | $-0.07 | $-2.69 | $-8.47 | $-15.97 | $-0.79 | — | — | — | — | — |
| Total Assets | $185.55M | $144.22M | $167.53M | $294.30M | $396.50M | $333.41M | $226.42M | $140.99M | $245.95M | $170.73M |
| Total Liabilities | $123.36M | $145.87M | $165.94M | $244.28M | $170.63M | $136.41M | $153.89M | $121.25M | $125.45M | $87.76M |
| Shareholders' Equity | $49.87M | $22.74M | $22.54M | $41.72M | $108.67M | $100.34M | $26.21M | $1.85M | $52.57M | $38.49M |
| Cash & Equivalents | $79.38M | $57.26M | $80.93M | $178.27M | $305.74M | $233.35M | $136.86M | $65.51M | $94.95M | $88.29M |
| Operating Cash Flow | -$65.78M | -$80.19M | -$128.22M | -$179.40M | -$116.54M | -$83.68M | -$94.96M | -$98.85M | -$81.31M | -$45.81M |
| Capital Expenditures | — | $0 | $63.0K | $2.71M | $4.57M | $1.93M | $2.35M | $7.08M | $648.0K | $6.37M |
| Shares Outstanding | 31.36M | 27.91M | 15.09M | 7.37M | 101.44M | 94.88M | 74.03M | 57.85M | 50.99M | 48.93M |